Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypercalcemia of Malignancy”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Not applicableWithdrawnNCT03516747
What this trial is testing

Preoperational Fine Needle Aspiration of Pathological Parathyroid Gland

Who this might be right for
Parathyroid AdenomaHypercalcemia
HaEmek Medical Center, Israel
Testing effectiveness (Phase 2)Study completedNCT00001277
What this trial is testing

Studies of Elevated Parathyroid Activity

Who this might be right for
HyperparathyroidismHypercalcemiaParathyroid Neoplasm+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1,553
Not applicableEnded earlyNCT00458796
What this trial is testing

Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone

Who this might be right for
Breast CancerHypercalcemia of MalignancyMetastatic Cancer+2 more
University of Leeds 1,500
Large-scale testing (Phase 3)Study completedNCT03280264
What this trial is testing

Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism

Who this might be right for
Parathyroid CarcinomaPrimary Hyperparathyroidism
Kyowa Kirin Co., Ltd. 18
Not applicableStudy completedNCT05022641
What this trial is testing

Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy

Who this might be right for
Parathyroid AdenomaParathyroid NeoplasmsParathyroid Cancer+2 more
University of Michigan 160
Large-scale testing (Phase 3)WithdrawnNCT00301886
What this trial is testing

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

Who this might be right for
Breast CancerHypercalcemia of MalignancyMetastatic Cancer+1 more
SWOG Cancer Research Network
Not applicableUnknownNCT01647503
What this trial is testing

Differentially Expressed Proteins in Sporadic Parathyroid Tumors

Who this might be right for
Primary HyperparathyroidismHypercalcemia
Post Graduate Institute of Medical Education and Research, Chandigarh 50
Testing effectiveness (Phase 2)Study completedNCT00896454
What this trial is testing

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Who this might be right for
Breast CancerHypercalcemia of MalignancyColon Cancer+13 more
Amgen 33
Testing effectiveness (Phase 2)Study completedNCT00060138
What this trial is testing

Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases

Who this might be right for
Breast CancerHypercalcemia of MalignancyMetastatic Cancer+1 more
Chugai Pharmaceutical
Large-scale testing (Phase 3)UnknownNCT00326820
What this trial is testing

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer

Who this might be right for
Breast CancerHypercalcemia of MalignancyMetastatic Cancer
Wales Cancer Trials Unit 1,404
Large-scale testing (Phase 3)Study completedNCT01460030
What this trial is testing

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Who this might be right for
Parathyroid CarcinomaHypercalcemiaPrimary Hyperparathyroidism
Kyowa Kirin Co., Ltd.
Large-scale testing (Phase 3)Study completedNCT00003884
What this trial is testing

Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone

Who this might be right for
Hypercalcemia of MalignancyLung CancerMetastatic Cancer+2 more
Novartis 600
Not applicableStudy completedNCT04299425
What this trial is testing

Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy

Who this might be right for
Parathyroid AdenomaParathyroid NeoplasmsParathyroid Hyperplasia+3 more
Vanderbilt-Ingram Cancer Center 160
Early research (Phase 1)Study completedNCT00051779
What this trial is testing

An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerMetastasis
Chugai Pharma USA
Not applicableStudy completedNCT01498276
What this trial is testing

Family Genetics Health Education and Healthy Behaviors

Who this might be right for
DiabetesCancerHeart Disease
National Human Genome Research Institute (NHGRI) 310
Early research (Phase 1)WithdrawnNCT01333267
What this trial is testing

One Week Comparison Study of PTH and PTHrP Infusions

Who this might be right for
OsteoporosisHypercalcemia of MalignancyHyperparathyroidism+1 more
University of Pittsburgh
Very early researchStudy completedNCT00580788
What this trial is testing

One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study

Who this might be right for
OsteoporosisHumoral Hypercalcemia of MalignancyHyperparathyroidism
University of Pittsburgh 14
Not applicableStudy completedNCT00001345
What this trial is testing

Studies of Inherited Diseases of Metabolism

Who this might be right for
Multiple Endocrine Neoplasia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 969
Not applicableStudy completedNCT00126386
What this trial is testing

Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community

Who this might be right for
CancerHypercalcemiaPain
Alberta Health services 11
Testing effectiveness (Phase 2)Study completedNCT01447914
What this trial is testing

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
National Cancer Institute (NCI) 16
Load More Results